About: Susan O'Brien

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Susan O'Brien Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

medical researcher

Attributes	Values
rdf:type	Item
description	wetenschapper (nl) дослідниця (uk) հետազոտող (hy) medical researcher (en) Narozena 25. 10. 1954, M.D., americká lékařka, zabývá se onkologií. Publikuje v oboru. (cs)
rdfs:label	Susan O'Brien (en) Susan O'Brien (es) Susan O'Brien (nl) Susan O'Brien (ast) Susan O'Brien (cs) Susan O'Brien (de) Susan O'Brien (fr) Susan O'Brien (it) Susan O'Brien (pt) Susan O'Brien (sk) Susan O'Brien (sq) Susan O'Brien (pt-br)
skos:prefLabel	Susan O'Brien (en) Susan O'Brien (es) Susan O'Brien (nl) Susan O'Brien (ast) Susan O'Brien (cs) Susan O'Brien (de) Susan O'Brien (fr) Susan O'Brien (it) Susan O'Brien (pt) Susan O'Brien (sk) Susan O'Brien (sq) Susan O'Brien (pt-br)
name	Susan O'Brien (en) Susan O'Brien (es) Susan O'Brien (nl) Susan O'Brien (ast) Susan O'Brien (cs) Susan O'Brien (de) Susan O'Brien (fr) Susan O'Brien (it) Susan O'Brien (pt) Susan O'Brien (sk) Susan O'Brien (sq) Susan O'Brien (pt-br)
given name	wds:Q66370727-9A9B355D-E4DB-45F2-A088-1B340DB996A7
given name	Susan
described by source	wds:Q66370727-20D28CE1-3D60-4043-8C0D-103AA3C5199F
instance of	wds:Q66370727-2E2E1A7C-6D1F-4E26-9007-8533E0B6740F
NL CR AUT ID	wds:Q66370727-CCB7BEB3-7134-48A1-8E2C-BD777F596819
described by source	Medvik
instance of	Homo sapiens
NL CR AUT ID	xx0131513
skos:altLabel	Susan M. O'Brien (en) Susan M. O'Brien (fr)
NORAF ID	wds:q66370727-5833bbd8-45cd-9c09-eafd-be759e285655
occupation	wds:Q66370727-6FE7F444-1A23-430C-85F3-493D2FBCED84
languages spoken, written or signed	wds:q66370727-6108046f-40cc-f4e0-0cda-1f37c15273d5
sex or gender	wds:Q66370727-EB657D00-382B-4A6D-BAE3-3A88345123BE
ISNI	wds:Q66370727-F593AC15-338D-49F4-AFE8-3B85C92EDC37
VIAF ID	wds:Q66370727-23FB990F-08CF-4DB3-9A79-BCB1B28C63BD
GND ID	wds:Q66370727-400c83e8-2e44-4f96-b386-b556aa5bad51
Library of Congress authority ID	wds:q66370727-798ce8a0-4cda-7859-d0b1-c3cce1409ab7
Bibliothèque nationale de France ID	wds:q66370727-8e3081b4-460d-88db-b115-4b06a28794f9
BNB person ID	wds:Q66370727-745847FB-B114-4F2E-8212-8517A147D6CF
date of birth	wds:Q66370727-647A7729-1C4C-4081-8E6C-CED58DF83A9A
writing language	wds:q66370727-6805a359-4e2a-042a-6870-2afde8625c4b
family name	wds:Q66370727-E087F7B1-91B0-498F-9607-64F0D044D940
WorldCat Identities ID (superseded)	wds:Q66370727-A5BBCBA0-B375-4C39-84E6-5A75A749B572
Canadiana Name Authority ID	wds:q66370727-fecfcbe0-4fae-a3e0-db44-f1f0f672a0a9
NORAF ID	https://livedata.bibsys.no/authority/11013721
VIAF ID	http://viaf.org/viaf/41324176
GND ID	https://d-nb.info/gnd/142969966
Library of Congress authority ID	http://id.loc.gov/authorities/names/n2008183079
Bibliothèque nationale de France ID	http://data.bnf.fr/ark:/12148/cb16549071c#about
BNB person ID	https://bnb.data.bl.uk/doc/person/OBrienSusan1954-
NORAF ID	11013721
occupation	physician
languages spoken, written or signed	English
sex or gender	female organism
ISNI	0000000114908122
VIAF ID	41324176
GND ID	142969966
Library of Congress authority ID	n2008183079
Bibliothèque nationale de France ID	16549071c
BNB person ID	OBrienSusan1954-
date of birth	1954-10-25 00:00:00Z (xsd:dateTime)
writing language	English
family name	O'Brien
WorldCat Identities ID (superseded)	lccn-n2008183079
Canadiana Name Authority ID	ncf11528631
ORCID iD	wds:Q66370727-D44632A4-108A-414D-89C4-34383A256A5C
ORCID iD	https://orcid.org/0000-0002-2481-7504
ORCID iD	0000-0002-2481-7504
is owl:sameAs of	Susan O'Brien Susan O'Brien
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q66370727
is author of	Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemia End points to establish the efficacy of new agents in the treatment of acute leukemia. Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia: the M. D. Anderson experience Phase I/II study of subcutaneous homoharringtonine in patients with chronic myeloid leukemia who have failed prior therapy.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software